High prevalence of iron deficiency exhibited in internationally competitive, non-professional female endurance athletesA case study
Key Questions Answered in the GLP-1 Agonists - Pipeline Insight Report Which companies/institutions are leading the GLP-1 agonists drug development
release of neurotransmitters, cell-to-cell signalling, cell adhesions, apoptosis, ionic transportation, enzyme regulation as well as protein covalent modifications, such as folding and maturation
It's a synthetic peptide that works through two gut-hormone pathways at once, GLP-1 and GIP, which is part of why it performs so well
GLP-1 is an incretin hormone naturally produced in the intestinal L-cells in response to food intake
Examining clinical correlates, treatment outcomes and mediators in young people with comorbid obsessive-compulsive disorder and autism spectrum disorder